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Administration of intracoronary verapamil via self-made perfusion balloon
to Treat No-Reﬂow Phenomenon following PCI in patients with Acute
Coronary Syndromes
Jincheng Guo, Wenming Chen, Guozhong Wang, Fuli Zhu, Rong Xu,
Zhenghai Zhang, Shunjin Gan
Beijing Luhe hospital, Capital Medical University
OBJECTIVES To evaluate the efﬁcacy and safety of intracoronary
administration of verapamil through self-made perfusion balloon,
with 2w4 holes punctured by needle at the end of a rapid exchange
balloon, to treat impaired blood ﬂow (no/slow reﬂow phenomenon,
NSF) in patients with acute coronary syndrome (ACS) during percu-
taneous coronary intervention (PCI).
METHODS This retrospective study was composed of 129 patients
who presented with ACS between January 2013 and August 2014, and
developed NSF during subsequent PCI. Of the 129 patients, primary
PCI was performed in 75 patients, rescue PCI in 1 patient and elective
PCI in 53 patients. NSF was observed in 90 patients (69.8%) at post-
stenting and 39 patients (30.2%) at postdilation. Verapamil, 200 to
1000mg by slow manually intracoronary infusion for at least 1min, was
given via the self-made perfusion balloon distal to the angioplasty
site, Where the blood ﬂow was the slowest. The primary end points
included ﬂow improvement in Thrombolysis In Myocardial Infarction
[TIMI] ﬂow grade, corrected thrombolysis in myocardial infarction
frame count (CTFC) and TIMI myocardial perfusion grade(TMP), ST
segment resolution in primary PCI patients after administration of
the verapamil and in-hospital and 30-day major adverse cardiac
events (MACE) including death, myocardial infarction, repeat
revascularization.
RESULTS There was a signiﬁcant improvement of TIMI-3 ﬂow, TMP-
0w1 and CTFC after intracoronary administration of verapamil (89.9%
vs 37.2%, p <0.001; 76.0% vs 11.6%, p <0.001; 6627 frames vs 3721
frames, p <0.001, respectively). At end of the procedure, TIMI 3 ﬂow
was achieved in 114 patients (88.4%), TMP 2w3 ﬂow in 98 patients
(76.0%). The rate for complete, partial and no ST segment resolution
was 31.6%, 26.3% and 42.1%, respectively. Transient complete atrio-
ventricular block occurred during verapamil injection to right coro-
nary artery in 2 patients, which disappeared after atropine. There was
no MACE in-hospital and 30-day except for 1 patient died of cardio-
genic shock in hospital.
CONCLUSIONS Intracoronary verapamil via self-made perfusion
balloon is an effective, safe treatment of NSF associated with PCI in
ACS patients.GW26-e4477
Safety and Efﬁcacy of using a single transRAdial MAC guiding catheter for
coronary angiograPhy and Intervention in patients with STE-MyocarDial
infarction (RAPID)
Jincheng Guo, Wenming Chen, Guozhong Wang, Rong Xu, Zijing Liu,
Shunjin Gan, Libin Zhang
Beijing Luhe hospital, Capital Medical University
OBJECTIVES Coronary intervention using transradial approach is
common worldwide. It is normally necessary to use one diagnostic
catheter and guiding catheter in primary percutaneous coronary
intervention (PCI) for ST elevation myocardial infarction (STEMI). It is
unknown whether using a single guiding catheter for both nonculprit
and culprit vessel angiography and intervention during transradial
primary PCI is feasible. The aim of this study is to investigate the
safety and feasibility of using a single guiding catheter (MAC 3.5) for
left and right coronary angiography and intervention in patients with
STEMI.
METHODS This was a single-center, prospective, randomized study
conducted from August 2011 to April 2014, 360 patients with STEMI
indicated for transradial primary PCI performed were randomized into
two groups: MAC group (180 cases) consisted of patients who under-
went coronary angiography and primary PCI by using a single guiding
catheter (MAC3.5). Control group (180 cases) included patients who
ﬁrst underwent coronary angiography with 5FTiger diagnostic cath-
eter followed by guiding catheter selection at the operator’s discretion
for intervention. The primary outcomes were catheterization labora-
tory door to balloon time (C2B). The secondary outcomes were major
adverse cardiac events (MACE) including composite of cardiac death,myocardial infarction target vessel revascularization, target lesion
revascularization and stent thrombosis at 30 days and 6 months.
Analyses were by intention to treat.
RESULTS Baseline patient characteristics were similar between the
MAC group and control group. the sheath placement time (2.21.8 min
vs 1.71.3 min), the PCI procedural success rate(91.7% vs 91.7%), door
to balloon time(87.139.4 min vs 85.635.0 min) and contrast con-
sumption (10337 ml vs 11041 ml) in the two groups were not sta-
tistically signiﬁcant(p >0.05). Compare with the Control group, C2B
time, total procedure time and the overall ﬂuoroscopy time were
signiﬁcantly lower in MAC Group (17.15.5 min vs 18.64 4.20 min,
p<0.001; 32.115.4 min vs 35.912.9 min, p ¼0.013; 8.9 3.8min vs 9.9
4.8 min, p ¼0.032, respectively). The 30-day MACE rates were 2.8%
and 2.2% in the MAC and control groups (p >0.05). No signiﬁcant
difference in MACE was observed at 6-month (5.6% vs 5.0%, p >0.05).
CONCLUSIONS A single transradial MAC 3.5 guiding catheter for
coronary angiography and intervention seems to be a better option for
patients with STEMI for whom primary PCI is planned. It can shorten
C2B time, procedure time and ﬂuoroscopy time. Further study is
required to determine whether this strategy can favorably affect
clinical outcomes.
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Establishment of an experimental angiographic slow coronary ﬂow model
by microsphere embolism in pigs
Yupeng Bai, Liqun Hu, Delong Yu, Sheng Peng, Xiaogang Liu,
Mingjing Zhang, Ye Gu
Department of Cardiology, Puai Hospital, Huazhong University of
Science and Technology
OBJECTIVES No-reﬂow or slow-ﬂow post revascularization remains a
challenge in interventional cardiology. Till now, there is no large
animal model with angiographic evidence of slow ﬂow. The objective
of this study is to establish a swine slow ﬂow model with angiographic
evidence mimicking the clinical situation.
METHODS In closed chest porcine, slow reﬂow was established in 8
pigs by repeated small amount left anterior descending coronary in-
jection of 40 mm microsphere injection till the appearance of angio-
graphic slow ﬂow: Thrombolysis in Myocardial Infarction (TIMI) frame
count (TFC)>40. TFC and TIMI myocardial perfusion grade (TMPG)
were determined in coronary angiography examinations (CAG). CAG
and left ventriculography were repeated at 4 weeks post procedure.
RESULTS One pig died at 2 days post microsphere injection and au-
topsy evidenced lung edema in this animal, another pig received
temporary mechanical ventilation due to breathing depression post
anesthesia and recovered. TFC was signiﬁcantly increased at the time
of establishment of no-reﬂow compared to baseline (59.819.4 vs.
15.83.4, p<0.05) and returned to baseline value (18.22.3) at 4 weeks
post procedure. Left ventricular (LV) end-diastolic volume (32.84.2
vs. 24.43.7 ml, p<0.05) and LV end-diastolic pressure (14.31.2 vs.
7.83.6mmHg, p<0.05) were higher, LV systolic pressure (1239 vs.
14715mmHg, p<0.05) and ejection fraction (585 vs. 685%,
p<0.05) were lower at 4 weeks post procedure compared to baseline
values.
CONCLUSIONS Angiographic no-reﬂow could be reliably induced in
porcine by coronary microsphere injection. This model may support
investigation on underlying mechanisms and new therapy options for
slow ﬂow phenomenon.GW26-e4529
Very Long-term Outcomes of Percutaneous Coronary Intervention with
Drug-eluting Stents versus Coronary Artery Bypass Grafting for Patients
with Unprotected Left Main Coronary Artery Disease
Fang Chen
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical
University and Beijing Institute of Heart Lung and Blood Vessel
Disease, Beijing
OBJECTIVES This study aimed at comparing the long-term (>5 years)
outcomes of patients with unprotected left main coronary artery
(ULMCA) disease underwent percutaneous coronary intervention
(PCI) with drug-eluting stents (DES) and coronary-artery bypass
grafting (CABG).
METHODS All consecutive patients with ULMCA disease treated with
DES implantation versus CABG in our center, between January 2003 to
July 2009, were screened for analyzing. A propensity score analysis
